Sebaceous carcinoma of the eyelids: personal experience with 60 cases

JA Shields, H Demirci, BP Marr, RC Eagle Jr… - Ophthalmology, 2004 - Elsevier
OBJECTIVE: To describe clinical features, management, and prognosis of sebaceous
carcinoma of the eyelid and adjacent structures. DESIGN: Single-center retrospective …

Sebaceous carcinoma of the ocular region: a review

JA Shields, H Demirci, BP Marr, RC Eagle Jr… - Survey of …, 2005 - Elsevier
Sebaceous carcinoma of the ocular region is a malignant neoplasm that is being recognized
more frequently and managed by innovative techniques of local resection, cryotherapy …

Treatment of uveal melanoma: where are we now?

J Yang, DK Manson, BP Marr… - … advances in medical …, 2018 - journals.sagepub.com
Uveal melanoma, a rare subset of melanoma, is the most common primary intraocular
malignancy in adults. Despite effective primary therapy, nearly 50% of patients will develop …

Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience

YP Gobin, IJ Dunkel, BP Marr, SE Brodie… - Archives of …, 2011 - jamanetwork.com
Objective: To determine whether intra-arterial chemotherapy is safe and effective in
advanced intraocular retinoblastoma. Retinoblastoma often presents with advanced …

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial

RD Carvajal, JA Sosman, JF Quevedo, MM Milhem… - Jama, 2014 - jamanetwork.com
Importance Uveal melanoma is characterized by mutations inGNAQandGNA11, resulting in
mitogen-activated protein kinase pathway activation. Objective To assess the efficacy of …

Uveal melanoma: epidemiology, etiology, and treatment of primary disease

BA Krantz, N Dave, KM Komatsubara… - Clinical …, 2017 - Taylor & Francis
Uveal melanoma (UM) is the most common intraocular malignancy and arises from
melanocytes in the iris, ciliary body, or choroid. Early diagnosis and local treatment is …

Metastatic disease from uveal melanoma: treatment options and future prospects

RD Carvajal, GK Schwartz, T Tezel, B Marr… - British Journal of …, 2017 - bjo.bmj.com
Uveal melanoma represents∼ 85% of all ocular melanomas and up to 50% of patients
develop metastatic disease. Metastases are most frequently localised to the liver and, as few …

Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery)

DH Abramson, IJ Dunkel, SE Brodie, B Marr, YP Gobin - Ophthalmology, 2010 - Elsevier
PURPOSE: To report on our 3-year experience with the use of superselective ophthalmic
artery infusion of chemotherapy as initial, primary treatment for intraocular retinoblastoma …

Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study

JH Francis, P Schaiquevich, E Buitrago, MJ Del Sole… - Ophthalmology, 2014 - Elsevier
Purpose Intravitreal melphalan is emerging as an effective treatment for refractory vitreous
seeds in retinoblastoma, but there is limited understanding regarding its toxicity. This study …

Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results

DH Abramson, BP Marr, IJ Dunkel, S Brodie… - British journal of …, 2012 - bjo.bmj.com
Background/aims To review the effectiveness of intra-arterial chemotherapy for advanced
intra-ocular retinoblastoma with vitreous and/or subretinal seeds in naive (untreated) and …